April 10, 2019

No Image

‘National Enquirer’ Publisher Looks To Sell Magazines

Host Ailsa Chang speaks to NPR’s David Folkenflik about the news that American Media intends to sell its tabloids, including National Enquirer.



AILSA CHANG, HOST:

This evening, the parent company of the National Enquirer announced its intention to sell the tabloid and several of its sister tabloids. This comes after a series of scandals and controversies that involved the Enquirer’s ties to President Trump. NPR media correspondent David Folkenflik joins me now. Welcome.

DAVID FOLKENFLIK, BYLINE: Hey, Ailsa.

CHANG: Hey. So what’s the company saying about why they’re interested in selling all of a sudden? Are they in financial trouble?

FOLKENFLIK: Well, if you believe the official line, they say they’re exploring and intend to sell the Enquirer, a couple of the sister tabloids because they want to focus on some of their more upscale lifestyle magazines. In the last year and a half or so, they acquired US Weekly and Men’s Journal from Jann Wenner’s media outfit. There is a financial cloud hovering over AMI, American Media Inc, the parent company of the National Enquirer. It declared bankruptcy in 2010. It’s got a lot of debt. But it’s impossible to think about this intended sale without thinking about all the scandals and controversies that have just wrapped themselves around this publication.

CHANG: Yeah. Can you take a moment to walk us through some of those controversies?

FOLKENFLIK: Yeah. And they’re pretty intense. Think back to what we learned over recent months from federal investigators about the Enquirer’s role in the 2016 campaign of Donald Trump. You know, if you looked on the covers, you saw all these stories damaging Hillary Clinton badly, helping Trump, portraying him in tight light. What we didn’t know during the campaign was that they had engaged by their own concession in an effort to pay a former Playboy model $150,000. She had said that she had had a significant romantic involvement with President Trump, and they did what they called catch and kill. They promised her a contract to print a column by her in Men’s Journal. But actually it was an effort to keep her story of her involvement with President Trump out of the public, particularly before the election. And that was a big one. The editor and the CEO, David Pecker, collaborated with federal prosecutors in order to avoid prosecution themselves for crimes.

CHANG: And then most recently the Enquirer tangled with Jeff Bezos, who owns both Amazon and The Washington Post.

FOLKENFLIK: That’s right. He’s the controlling owner and one of the richest people on the globe. He is the personal owner of The Washington Post. And that’s an important element. The National Enquirer had been intently going over his personal life intending to reveal elements of his extramarital involvement with his girlfriend. And he took to Medium and posted a long thing saying that actually National Enquirer was trying to blackmail him into making a statement saying that they weren’t acting in any way out of political motivation and that he felt that they were.

And his people have suggested – he suggested that in fact they were acting on behest of Saudi Arabian interests, an interesting note to strike in part because it appeared as though there was some possible financial involvement of some Saudi investors in American media even if that didn’t fully play out. So one of the elements of this of course is Jeff Bezos’ Washington Post is one of the chief media antagonists of President Trump.

CHANG: Right.

FOLKENFLIK: It’s really attacked the Post for its reporting. And so there seems to be that element at play there as well. The Washington Post is reporting that the hedge fund manager who essentially controls the parent company got fed up with all the scandal after the Jeff Bezos story.

CHANG: So what’s next? Are there any potential buyers circling the Enquirer already?

FOLKENFLIK: Well, you know, it’s an incredible brand. It’s survived a lot of controversies in the past. In order to talk to you this evening, I ducked out of a Broadway show about Rupert Murdoch and The Sun, a British tabloid. It’s had a lot of controversies in the past. It survived. I’d be surprised if the Enquirer didn’t live to see another day.

CHANG: That’s NPR’s media correspondent David Folkenflik. Thanks, David.

FOLKENFLIK: You bet.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

The federal government is charging the maker of the addiction drug Suboxone with fraud and conspiracy in marketing the drug to doctors.



ARI SHAPIRO, HOST:

Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges. Indivior makes the drug Suboxone, widely used to treat people suffering from opioid addiction. Federal prosecutors now claim the company falsely marketed Suboxone as safer and less prone to abuse than cheaper generic drugs. North Country Public Radio’s Brian Mann reports.

BRIAN MANN, BYLINE: The 28-count indictment filed in a Virginia court claims Indivior executives lied when they claimed dissolvable Suboxone films placed under the tongue would be safer, harder to misuse than generic tablets that were about to come on the market. Government investigators say, in some cases, Indivior’s version of the drug was more risky. The indictment claims taxpayer-funded programs like Medicare and Medicaid were cheated out of billions of dollars. Justice Department officials declined NPR’s request for an interview. Robert Bird is a professor of business law at the University of Connecticut who follows opioid cases closely. He says this criminal indictment sends a powerful signal to a drug industry already snared in the opioid addiction crisis.

ROBERT BIRD: Not only the companies that are being indicted but also other organizations and competitors who will look at these prosecutions and say, I don’t want this to happen to me.

MANN: Indivior executives also declined to be interviewed by NPR. But company spokesperson Jennifer Ginther read from a prepared statement, denying any wrongdoing and describing the federal indictment as misguided.

JENNIFER GINTHER: Indivior’s top priority has always been the treatment of patients struggling with opioid addiction. No other company has done more to fight the opioid crisis.

MANN: This point – Indivior’s central role treating people addicted to opioids – represents a fascinating wrinkle in this case. The Justice Department has filed criminal charges against other opioid makers in the past, winning a guilty plea in a $600 million settlement from Purdue Pharma, the maker of OxyContin in 2007. But Indivior doesn’t actually make prescription painkillers. It makes drugs like Suboxone designed to treat people suffering from opioid dependency.

ALAN LESHNER: It’s a highly effective medication that we endorse in our report.

MANN: Alan Leshner chaired a panel for the National Academies of Sciences, Engineering, and Medicine that released a new study last month finding that drugs like Suboxone are being underutilized. He worries that all the bad publicity surrounding drug companies and their products will make it harder for people struggling with opioid addiction to get treatment drugs.

LESHNER: So there’s a tremendous amount of stigma surrounding everything related to addiction. And the stigma and misunderstanding has kept a tremendous number of people from getting the treatment that they need.

MANN: These recovery drugs matter because more than 100 Americans are still dying from opioid overdoses every day. But like other medications that contain opioids, Suboxone can be abused. This federal indictment claims that while Indivior downplayed the risks of their drugs, the company also boosted profits by helping create a black market connecting patients suffering from addiction with doctors writing too many prescriptions for Suboxone at too strong a dose. In its statement, Indivior rejected that claim, saying the company never deliberately diverted its product to increase sales.

The stakes here are high. If Indivior is found guilty, prosecutors say the company should forfeit at least $3 billion in penalties. Indivior and other big drugmakers, including Purdue Pharma and Johnson & Johnson, already faced hundreds of civil lawsuits stemming from the opioid crisis. Brian Mann, NPR News.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

A Look At The Legacy Dirk Nowitzki Is Leaving In Dallas After His 21-Year NBA Career

NPR’s Ailsa Chang speaks with sports radio host Donovan Lewis about Dirk Nowitzki’s 21-year NBA career with the Dallas Mavericks after his final home game.



AILSA CHANG, HOST:

All right, Dallas, Texas, has long been known as a football town where the silver star looms large. But sports fans paid new attention to basketball when a 7-foot German player named Dirk Nowitzki joined the Dallas Mavericks in 1998. Now Nowitzki has officially announced he’s retiring after this season, his 21st with the Mavericks. Here he is at last night’s ceremony.

(SOUNDBITE OF ARCHIVED RECORDING)

DIRK NOWITZKI: As you guys might expect, this was my last home game – yeah.

CHANG: Over the decades, Nowitzki and his Dallas fan base forged a deep bond. And to talk more about that, let’s bring in Donovan Lewis, who’s a sports radio host at The Ticket in Dallas. Hey, Donovan.

DONOVAN LEWIS: Hello. How are you?

CHANG: I’m good. So you’ve been there for most of Nowitzki’s career. What was the atmosphere like last night for his final game in Dallas?

LEWIS: I think we all thought that this was his final year and his final home game, but Dirk never let on that it was officially the end. So, you know, you always hold on hope because this guy brought so much joy to every single basketball fan in Dallas because we all thought for a long time that basketball just wasn’t going to be king around here and we never would…

CHANG: Yeah.

LEWIS: …Get a title. But this guy came in. And all of a sudden, he just won us over. And they played relevant basketball in Dallas for a decade and a half. And I don’t think a lot of people realize or appreciate that because we just got spoiled because basketball was so good, and it was…

CHANG: Yeah.

LEWIS: …All because of this one guy. We won a title…

CHANG: Yeah.

LEWIS: …In 2011, and that’s climbing a mountain. And that’s like, OK, this is the ultimate. You know what? I’ll take that back. I love the title, but the ultimate was celebrating the guy that’s been here for two decades…

CHANG: Yeah, yeah.

LEWIS: …Playing basketball. He’s one of ours, and I just absolutely loved it.

CHANG: I mean, it wasn’t just the fans who adored him. He loved Dallas. He spent 21 seasons with the Mavericks. Why do you think Nowitzki felt so loyal to Dallas?

LEWIS: I think Mark Cuban, the owner of the Mavericks, had a lot to do with it. And I think winning that title had a lot to do it also – with it all so. This town was so starved for success in basketball.

CHANG: (Laughter).

LEWIS: And OK, maybe you were close to climbing that mountain, and it didn’t happen. So being here for so long, he wanted to do it for this city. And once that happened, it was like, OK, this guy sacrificed blood, sweat and tears. We see, we hear that all the time.

CHANG: Yeah.

LEWIS: But that’s literally what happened.

CHANG: Now, a few of Nowitzki’s his favorite players, I understand, were in attendance last night. They made speeches about him. Here’s what Charles Barkley had to say.

(SOUNDBITE OF ARCHIVED RECORDING)

CHARLES BARKLEY: Let me say this about Dirk Nowitzki. He’s the nicest man ever.

(CHEERING, APPLAUSE)

CHANG: There it is, that love again. Why do you think so many people felt such a personal connection to this guy?

LEWIS: A, because it’s true. He is the nicest guy ever. And for him to be a superstar, one of – I guess we kind of equate superstars as being a little standoffish. I mean, you have to because a lot of people demand a lot of your time, whether it’s pictures or autographs or whatnot. Social media yesterday was filled with people posting their pictures with Dirk, just ordinary people.

CHANG: Well what about you? Do you have a favorite personal story with Dirk?

LEWIS: You know, on our radio show, we have a yearly interview with Dirk. The first time I met him was 2007, and I’m starstruck. This is the – my favorite basketball player, and he’s sitting right down and talking to us. Even every year after that, he’d come up, and he would remember my name and sit down and talk and all that stuff. So it’s really crazy to think that this guy that you see on TV that’s doing all the things that he’s doing and winning championships will sit down and, you know, know you by name. It’s – it kind of blows your mind a little bit. But he’s just that kind of guy.

CHANG: Donovan Lewis with The Ticket in Dallas, thanks so much for joining us.

LEWIS: Thank you for having me. It’s my pleasure – anytime.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)